Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Akuugo intracerebral transplantation injection for chronic motor paralysis after traumatic brain injury
jRCT2033240263Not yet recruiting
- Sponsor
- SanBio
- Start
- Jul 2025
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Randomised, open-label trial of apitegromab in traumatic brain injury (TBI) (2 arms), sponsored by SanBio. Primary endpoint: Mean change from baseline in FMMS at Week 24. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
apitegromab
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on jRCT2033240263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2033240263.